The COVID-19 panic has worked wonders for Big Pharma's public image
Mark Crispin Miller
Pharma's reputation has soared during COVID-19 pandemic, poll finds
Consumers' impression of pharma companies has soared during the COVID-19 pandemic, with 40% now reporting that they have a more positive view of the industry than they did before the pandemic began, according to recent data from The Harris Poll.
The positive sentiment, expressed by survey respondents between April 11 and April 13, represents upward momentum. Between March 21 and 23, only 33% of Americans said their view of pharma had gotten more positive. Harris Poll has been tracking the impact of the COVID-19 pandemic on consumer views across a wide swath of industries for the past six weeks.
While industry experts and watchers have been cautiously optimistic that the pharma industry's concerted efforts to fight COVID-19 might result in a reputation boost, the Harris Poll data is the first major market survey to show clear evidence.
Pharma’s boost in the survey wasn’t as high as healthcare workers' or grocery store retailers', but as Harris Poll managing director Rob Jekielek noted, its uptick outranks other industries that might have expected a reputation boost, such as financial services or automotive.
Click on the link for the rest.